History of smoking cessation treatment in Poland – the strengthening role of cytisine as the most effective and safe pharmacotherapy

Zatoński, Witold; Janik-Koncewicz, Kinga; Stępnicka, Zuzanna; Zatońska, Katarzyna; Połtyn–Zaradna, Katarzyna; Herbeć, Aleksandra

doi:10.5114/jhi.2020.102969

Cited by 2 publications

(3 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another potential reason for the low popularity of ENDS among adults in Poland might be the unique landscape of smoking cessation pharmacotherapy in the country. As ENDS were being introduced on the market, at the same time Poland has seen the growth in popularity of pure nicotine for cessation as well as the use of cessation drugs in the form of nicotine partial agonists acting on central nervous system based on cytisine [32]. Sales of smoking cessation drugs in Poland is one of the highest in Europe [32,33] and continues to grow.…”

Section: Discussionmentioning

confidence: 99%

“…As ENDS were being introduced on the market, at the same time Poland has seen the growth in popularity of pure nicotine for cessation as well as the use of cessation drugs in the form of nicotine partial agonists acting on central nervous system based on cytisine [32]. Sales of smoking cessation drugs in Poland is one of the highest in Europe [32,33] and continues to grow. After 2000, the quantity and value of sales of pure nicotine for medical use increased few times [34].…”

Section: Discussionmentioning

confidence: 99%

“…Additionally, Poland remains the only country where cytisine is used on a population scale. Polish scientists introduced cytisine into the Polish market after a series of clinical reports and trials conducted between 2006 and 2011 confirmed its effectiveness [32,33,35,36]. The main placebocontrolled trial of cytisine for smoking cessation was published in New England Journal of Medicine in 2011 [36].…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Use of Electronic Nicotine Delivery Systems (ENDS) in Poland in 2019

Janik-Koncewicz¹,

Zatoński²,

Zatoński³

2021

jhi

Self Cite

View full text Add to dashboard Cite

Background:The introduction of Electronic Nicotine Delivery Systems (ENDS) was suspected to be a factor disrupting the stable decline in the nicotine and tobacco market in Poland. Materials and method: A cross-sectional study was conducted in 2019 on a representative sample of 1077 Polish adults aged 18 years and used face-to-face interviews. ENDS use was analysed from respondents aged 20 years and older by gender, age, place of residence and education. Calculations were done using IBM SPSS Statistics 25. Results: Only 3.0% of men and 0.7% of women in Poland were daily (regular) ENDS users in 2019, while 1.6% of men and 0.7% of women were occasional users. The vast majority of respondents (97%) declared that they did not use ENDS at all. ENDS use was most prevalent in the youngest age group (5.3% in men, 1.3% in women), and in urban than rural areas (4.1% of men and 0.9% of women in urban areas vs 1.5% of men and 0.5% of women in rural areas), in men with a secondary education (4.3%), and in women with a primary education (1.2%). Three percent of men (3.1%) were daily (regular) dual users of conventional cigarettes and ENDS, and 3.5% of men using conventional cigarettes used ENDS in exceptional situations (occasionally). Conclusions: Our study showed that despite a decline in conventional cigarette smoking, the prevalence of ENDS use among adults in Poland is low and it did not increase in the recent years. This stands in contrast with research showing that Poland has some of the highest rates of ENDS use among children. However, the system of monitoring of ENDS use in Poland needs to be improved, as the existing data for Poland remains scattered, of poor quality, and based on small samples.

show abstract

Section: Discussionmentioning

confidence: 99%